The company wants AI to support all complex diagnostic decisions by 2030 to prevent diagnostic errors and delays.
Creating capacity across continuum by implementing in-home acute and transitional care models that improve health system throughput and patient flow.
Organoids and engineered systems are transforming malaria research, improving drug discovery and understanding of Plasmodium ...